SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Chiron
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
1352 17 0 CHIR
Emcee:  Dahmane Dahmani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
427 Chiron grossly undervalued? Am I the only one that thinks Chiron is undervalueFrank DiLorenzo-2/13/1997
426 AIDS vaccine niaid.nNathan L.-2/12/1997
425 SEC filing 2/6 Prudential is selling 2mil.celeryroot.com-2/11/1997
424 I was watching the trades yesterday and some big blocks were sold (50k) . I wonceleryroot.com-2/11/1997
423 Cephalon and Chiron Submit New Drug Application For Myotrophin to Food and DrugNathan L.-2/11/1997
422 THIS is interesting....no mention in local (SF) papers. " Abbott Laboratoceleryroot.com-2/10/1997
421 I hope someone could help out with this question...Nathan...or anyone ???? We Joe Fang-2/9/1997
420 Your right. I still think a buyout is a long shot and that CHIR is better off ievan balter-2/9/1997
419 Evan....Unless Novartis is a willing seller of its almost 50% of the stock of Caknahow-2/9/1997
418 Regarding buyout: I can't decide if the buyout theory makes more sense befoevan balter-2/9/1997
417 Previous post have dealt with the buyout issue very well. While a buyout is poaknahow-2/9/1997
416 Frank D. I agree that a buy out would be a plus for Chiron now that Dr. PenhoetSStam-2/9/1997
415 Robert, Besides Betaseron, Regranex (The wound healing agent) Myotropin forSStam-2/9/1997
414 Frank, A couple of explanations on why intangible assets are low. I haven'Exacctnt-2/8/1997
413 Intangible Assets ... Any thoughts on Chiron's intangible assets. They seeFrank DiLorenzo-2/8/1997
412 Rec in mail today. Donaldson, Lufkin & Jenrette 2-5-97 Rating: Buy change: Susan Saline-2/7/1997
411 Joe: I agree with your assesment and only wish to add that I recently read an AARON DIDICH-2/6/1997
410 I think that the only buyout possiblity would be by Novartis (Ciba Geigy-SandozJoe Fang-2/5/1997
409 I think this baby is headed up soon, but not due to a buyout. Too much insiderKenneth E. De Paul-2/5/1997
408 Chiron looks undervalued relative to some other biotechs. A buyout by a major Frank DiLorenzo-2/5/1997
407 Last week I added about 3% to my overall holding in CHIR at $18 3/8, so it'OldAIMGuy-2/5/1997
406 Goldman: raises market perform to out perform Wertheim: reaffirms buy Brown epicure-2/5/1997
405 Chiron upgraded this morning by Goldman Sachs to Buy (from neutral I think) basNathan L.-2/5/1997
404 Nathan...I got a hard copy of th PR today and am going to microscope it later tJoe Fang-2/4/1997
403 CHIRON REPORTS FOURTH QUARTER 1996 RESULTS Business Editors/Health &Robert Mayo-2/4/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News